Itonis Pharmaceuticals Announces Completion of Stability Test
for Emesyl® and Delivery Date of Emesyl® with New Packaging
Design
LAGUNA HILLS, CA - December 18, 2014 - InvestorsHub NewsWire -
Itonis, Inc. (OTC
PINKSHEETS: ITNS)
Itonis is pleased to announce that it has received confirmation
from its manufacturer, Oasis Health Products, that its Emesyl®
nausea relief product has passed its Stability Test to enable the
company to market Emesyl® with a 2-year expiration date.
Oasis Health Products has also confirmed that Itonis will
receive delivery by December 19, 2014 of Emesyl® with its new
packaging design.
"We are pleased to see the successful completion of
the 90-day stability test which will enable the Company to package
and sell Emesyl® with a 2-year expiration,” said Mark Cheung, CEO
of Itonis, Inc. "We appreciate our shareholders' support and
patience, and are eager to begin the selling of Emesyl® to generate
revenues for the Company."
The Company also looks forward to delivery of the MyECheck, Inc.
point-of-sale app in early 2015.
About Itonis Pharmaceuticals
Itonis Pharmaceuticals, a division of Itonis, Inc., is headed by
Charles Hensley, Ph.D., and its mission is to create and market
over-the-counter and prescription homeopathic products that better
people's lives. Dr. Hensley is a pioneer in the development and
marketing of safe and effective therapeutic nutraceutical and
homeopathic preparations. He was a founder of the company
that launched the Zicam® Cold Remedy, making the product a
household name and forever changing the marketing and product
placement paradigm for homeopathic drugs in the United
States. Dr. Hensley and his team plan to use the same
methodologies to revolutionize the treatment of several other
common ailments and other chronic diseases.
About Itonis, Inc.
Located in Laguna Hills, California, and founded in 2005, Itonis
Inc. has focused on transitioning itself in the past year from
acquiring high growth, market niche entrepreneurial companies, to a
market leader focused on the distribution of innovative products to
the medical and pharmaceutical industry. Please visit www.itonisholdings.com.
About Emesyl®
www.itonisholdings.com/emesyl
About Oasis
www.oasishp.com/home/about/
Safe Harbor:
Statements in this press release may constitute forward-looking
statements and are subject to numerous risks and uncertainties,
including the failure to complete successfully the development of
new or enhanced products, the Company's future capital needs, the
lack of market demand for any new or enhanced products the Company
may develop, any actions by the Company's affiliates that may be
adverse to the Company, the success of competitive products, other
economic factors affecting the Company and its markets, seasonal
changes, and other risks detailed from time to time in the
Company's filings with the U.S. Securities and Exchange Commission.
The actual results may differ materially from those contained in
this press release. The Company disclaims any obligation to update
any statements in this press release.
Contact:
Itonis, Inc.
Office@itonisholdings.com
